Theodore R. Schroeder - Sep 30, 2021 Form 4 Insider Report for Nabriva Therapeutics plc (NBRV)

Role
Chief Executive Officer, Director
Signature
/s/ Christopher Naftzger, by power of attorney
Stock symbol
NBRV
Transactions as of
Sep 30, 2021
Transactions value $
-$127
Form type
4
Date filed
10/4/2021, 04:14 PM
Previous filing
Sep 15, 2021
Next filing
Oct 8, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NBRV Ordinary Shares Tax liability -$127 -107 -0.05% $1.19 227K Sep 30, 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These ordinary shares were withheld by the Issuer in order to satisfy tax withholding obligations upon the vesting of certain restricted share units.